| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/18/2012 | CN101940758B Traditional Chinese medicinal composition for treating liver diseases, preparation method thereof and application thereof |
| 01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
| 01/18/2012 | CN101810644B Production method of ant essential oil and ant oil soft capsule |
| 01/18/2012 | CN101773568B Traditional Chinese medicine composite for warming and invigorating qi and blood and preparation method and quality control method thereof |
| 01/18/2012 | CN101698085B Medicine composite for treating early liver fibrosis or early hepatocirrhosis decompensation, preparation method and application |
| 01/18/2012 | CN101695523B Lactation qi and blood tonifying medicament and preparation method thereof |
| 01/18/2012 | CN101670008B Deer fetus film and manufacturing method thereof |
| 01/18/2012 | CN101628080B Chinese medicinal capsule for tonifying kidney and strengthening yang |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101473999B Health-care type electronic smoke liquid for preventing and treating decayed tooth |
| 01/18/2012 | CN101301396B Medicament for treating oral ulcer of children and preparation thereof |
| 01/17/2012 | US8097653 Dosage unit comprising a prostaglandin analog for treating constipation |
| 01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8097289 Papaya puree and the use of the same |
| 01/17/2012 | US8097247 Probiotic, lactic acid-producing bacteria and uses thereof |
| 01/17/2012 | CA2515370C Compounds with hcv replication inhibition activity |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2470255C N4-acylcytosine nucleosides for treatment of viral infections |
| 01/17/2012 | CA2451244C Purine derivatives as a2b adenosine receptor antagonists |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2413195C Ligand to gpr8 and dna thereof |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/12/2012 | WO2012006512A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006497A2 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | WO2012006398A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 01/12/2012 | WO2012005240A1 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 01/12/2012 | WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 01/12/2012 | WO2012004273A2 Array of age-tailored nutritional formula with optimum fat content |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 01/12/2012 | WO2012003804A1 Pharmaceutical composition of silybin and preparation method thereof |
| 01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
| 01/12/2012 | WO2011117322A3 Use of caffeine and aspirin in synergistic amounts for improving performance |
| 01/12/2012 | WO2011107867A3 Compound and composition and their use in the treatment of diseases related to copper retention |
| 01/12/2012 | WO2011089012A3 Carob bean meal (ceratonia siliqua) for the treatment of diarrhea |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010279 Composition comprising (-)-delta9-trans-tetrahydrocannabinol |
| 01/12/2012 | US20120010273 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 01/12/2012 | US20120010244 Indole derivatives as ikk2 inhibitors |
| 01/12/2012 | US20120010236 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine |
| 01/12/2012 | US20120010223 Isothiazolo-pyrimidinedione derivatives as trpai modulators |
| 01/12/2012 | US20120010214 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES |
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010158 Tumor necrosis factor inhibiting peptides and uses thereof |
| 01/12/2012 | US20120010157 Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 01/12/2012 | US20120010155 Gntiii expression in plants |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/12/2012 | US20120009273 Kit of pharmaceutical formulations characterized by the presence of molecular oxygen |
| 01/12/2012 | US20120009264 Drug carrier for treating of gastrointestinal ulcer |
| 01/12/2012 | US20120009256 Treatment Including Prebiotic Composition for use with Probiotics |
| 01/12/2012 | US20120009229 Pharmaceutical compositions and related methods of delivery |
| 01/12/2012 | US20120009228 Prebiotic Compositions for use with Probiotics to Increase Probiotic Growth Rate and Activity |
| 01/12/2012 | US20120009226 Highly pure laquinimod or a pharmaceutically acceptable salt thereof |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009183 Method for treatment of pancreatitis |
| 01/12/2012 | US20120009167 Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 01/12/2012 | US20120009164 Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition |
| 01/12/2012 | US20120009163 Means and methods for activating vagus nerve |
| 01/12/2012 | US20120009155 Prebiotic Composition for Increasing Probiotic Growth Rate and Activity |
| 01/12/2012 | US20120009154 Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | CA2810170A1 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | CA2804926A1 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 01/12/2012 | CA2804918A1 N-hydroxyformamide derivative and medicament containing same |
| 01/12/2012 | CA2804666A1 Methods of immune modulation |
| 01/12/2012 | CA2803787A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 01/12/2012 | CA2802807A1 Array of age-tailored nutritional formula with optimum fat content |
| 01/11/2012 | EP2404918A1 Pyridine derivative |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2404507A1 Array of age-tailored nutritional formula with optimum fat content |
| 01/11/2012 | EP2403854A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| 01/11/2012 | EP2403510A1 Bacteria strains having a high anti-inflammatory activity |
| 01/11/2012 | EP2403495A1 Metadoxine for use as inhibitor of hepatic fibrosis |
| 01/11/2012 | EP1869023B1 New tricyclic angiotensin ii agonists |
| 01/11/2012 | EP1569904B1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | CN1969937B Pharmaceutical composition for treating hepatitis |
| 01/11/2012 | CN1642542B Angiogenesis inhibitors |
| 01/11/2012 | CN102317307A Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 01/11/2012 | CN102317282A Hetero ring derivative |
| 01/11/2012 | CN102317280A Oxyindole derivatives with motilin receptor agonistic activity |
| 01/11/2012 | CN102316900A Aniline derivative having anti-rna viral activity |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102316864A Chronotherapeutic pharmaceutical composition |
| 01/11/2012 | CN102311932A Lactobacillus salivarius for improving bacterial population in oral cavity and health-care composition thereof |
| 01/11/2012 | CN102311500A Antiviral fusion protein and application thereof |
| 01/11/2012 | CN102311485A Polypeptide with neovascularization suppression effect and application thereof |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102311385A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/11/2012 | CN102309767A Soluble osthole clathrate, dispersing tablet and preparation method thereof |
| 01/11/2012 | CN102309764A Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 01/11/2012 | CN102309758A Medicinal composition for treating diseases caused by enterovirus infections |